Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Gregory Palmer
Duke University, Department: Biomedical Engineering
Should you be removed from our database? Contact us at [email protected]. Read more below.
Zenalux Biomedical, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Palmer is a co-inventor of the Monte Carlo intellectual property that is licensed to Zenalux Biomedical. He receives royalties through the institution, receives consulting income, and owns equity options. Dr. Palmer serves as a Research Associate on this award that uses the intellectual property.
A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins
Our long-term scientific aim is to develop and apply a novel optical strategy for intra-operative assessment of breast tumor margins. The technology we propose to develop will be pragmatically designed and refined for use in an intra-operative setting. A tool for intra-operative margin assessment is significantly relevant to public in that it will contribute to a decrease in re-excision surgeries in patients with breast cancer.
Filed on July 25, 2012.
Tell us what you know about Gregory Palmer's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Gregory Palmer”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Gregory Palmer | Duke University | Conflict of Interest | Zenalux Biomedical, Inc. | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.